SuppreMol obtains license for RA antibody from the University Hospital Regensburg
04:10 EDT 27 Jul 2012 | Bionity
The Bayerische Patentallianz GmbH licences an antibody directed against interleukin 3 (IL-3), which has been generated at the University Hospital Regensburg, to SuppreMol GmbH, a privately held biopharmaceutical company developing innovative therapeu..
Original Article: SuppreMol obtains license for RA antibody from the University Hospital Regensburg
More From BioPortfolio on "SuppreMol obtains license for RA antibody from the University Hospital Regensburg"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
